Gellad ZF, Provenzale D: Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology. 2010, 138: 2177-2190. 10.1053/j.gastro.2010.01.056.
Article
PubMed
Google Scholar
Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N: Colorectal cancer. Lancet. 2010, 375: 1030-1047. 10.1016/S0140-6736(10)60353-4.
Article
PubMed
Google Scholar
Cuezva JM, Ortega AD, Willers I, Sanchez-Cenizo L, Aldea M, Sanchez-Arago M: The tumor suppressor function of mitochondria: Translation into the clinics. Biochim Biophys Acta. 2009, 1792: 1145-1158.
Article
CAS
PubMed
Google Scholar
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7: 11-20. 10.1016/j.cmet.2007.10.002.
Article
CAS
PubMed
Google Scholar
Kroemer G, Pouyssegur J: Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008, 13: 472-482. 10.1016/j.ccr.2008.05.005.
Article
CAS
PubMed
Google Scholar
Tennant DA, Duran RV, Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat Rev Cancer. 2010, 10: 267-277. 10.1038/nrc2817.
Article
CAS
PubMed
Google Scholar
Pelicano H, Martin DS, Xu RH, Huang P: Glycolysis inhibition for anticancer treatment. Oncogene. 2006, 25: 4633-4646. 10.1038/sj.onc.1209597.
Article
CAS
PubMed
Google Scholar
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009, 458: 780-783. 10.1038/nature07733.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lopez-Rios F, Sanchez-Arago M, Garcia-Garcia E, Ortega AD, Berrendero JR, Pozo-Rodriguez F, Lopez-Encuentra A, Ballestin C, Cuezva JM: Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res. 2007, 67: 9013-9017. 10.1158/0008-5472.CAN-07-1678.
Article
CAS
PubMed
Google Scholar
Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC: The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res. 2002, 62: 6674-6681.
CAS
PubMed
Google Scholar
Sanchez-Arago M, Chamorro M, Cuezva JM: Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis. 2010, 31: 567-576. 10.1093/carcin/bgq012.
Article
CAS
PubMed
Google Scholar
Bi X, Lin Q, Foo TW, Joshi S, You T, Shen HM, Ong CN, Cheah PY, Eu KW, Hew CL: Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol Cell Proteomics. 2006, 5: 1119-1130. 10.1074/mcp.M500432-MCP200.
Article
CAS
PubMed
Google Scholar
Chen J, Kahne T, Rocken C, Gotze T, Yu J, Sung JJ, Chen M, Hu P, Malfertheiner P, Ebert MP: Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res. 2004, 3: 1009-1016. 10.1021/pr049916l.
Article
CAS
PubMed
Google Scholar
Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.
Article
CAS
PubMed
Google Scholar
He QY, Chen J, Kung HF, Yuen AP, Chiu JF: Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics. 2004, 4: 271-278. 10.1002/pmic.200300550.
Article
CAS
PubMed
Google Scholar
Isidoro A, Casado E, Redondo A, Acebo P, Espinosa E, Alonso AM, Cejas P, Hardisson D, Fresno Vara JA, Belda-Iniesta C: Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis. 2005, 26: 2095-2104. 10.1093/carcin/bgi188.
Article
CAS
PubMed
Google Scholar
Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, Reed JC, Cuezva JM: Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J. 2004, 378: 17-20. 10.1042/BJ20031541.
Article
PubMed Central
CAS
PubMed
Google Scholar
Unwin RD, Craven RA, Harnden P, Hanrahan S, Totty N, Knowles M, Eardley I, Selby PJ, Banks RE: Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics. 2003, 3: 1620-1632. 10.1002/pmic.200300464.
Article
CAS
PubMed
Google Scholar
Lin PC, Lin JK, Yang SH, Wang HS, Li AF, Chang SC: Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis. 2008, 23: 1223-1232. 10.1007/s00384-008-0539-4.
Article
PubMed
Google Scholar
Ortega AD, Sala S, Espinosa E, Gonzalez-Baron M, Cuezva JM: HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence. Carcinogenesis. 2008, 29: 2053-2061. 10.1093/carcin/bgn185.
Article
CAS
PubMed
Google Scholar
Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung MS, Lim SJ, Park JG: Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res. 2005, 65: 3162-3170.
CAS
PubMed
Google Scholar
Li RJ, Zhang GS, Chen YH, Zhu JF, Lu QJ, Gong FJ, Kuang WY: Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. Ann Oncol. 2010, 7: 1506-1514. 10.1093/annonc/mdp569.
Article
Google Scholar
Hernlund E, Hjerpe E, Avall-Lundqvist E, Shoshan M: Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment. Mol Cancer Ther. 2009, 8: 1916-1923. 10.1158/1535-7163.MCT-09-0179.
Article
CAS
PubMed
Google Scholar
Hernlund E, Ihrlund LS, Khan O, Ates YO, Linder S, Panaretakis T, Shoshan MC: Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. Int J Cancer. 2008, 123: 476-483. 10.1002/ijc.23525.
Article
CAS
PubMed
Google Scholar
Geschwind JF, Ko YH, Torbenson MS, Magee C, Pedersen PL: Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res. 2002, 62: 3909-3913.
CAS
PubMed
Google Scholar
Bickis IJ, Quastel JH: Effects of Metabolic Inhibitors on Energy Metabolism of Ehrlich Ascites Carcinoma Cells. Nature. 1965, 205: 44-46. 10.1038/205044a0.
Article
CAS
PubMed
Google Scholar
Ganapathy-Kanniappan S, Geschwind JF, Kunjithapatham R, Buijs M, Vossen JA, Tchernyshyov I, Cole RN, Syed LH, Rao PP, Ota S, Vali M: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is pyruvylated during 3-bromopyruvate mediated cancer cell death. Anticancer Res. 2009, 29: 4909-4918.
PubMed Central
CAS
PubMed
Google Scholar
Pigault C, Follenius-Wund A, Schmutz M, Freyssinet JM, Brisson A: Formation of two-dimensional arrays of annexin V on phosphatidylserine-containing liposomes. J Mol Biol. 1994, 236: 199-208. 10.1006/jmbi.1994.1129.
Article
CAS
PubMed
Google Scholar
Jaattela M: Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene. 2004, 23: 2746-2756. 10.1038/sj.onc.1207513.
Article
PubMed
Google Scholar
Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB: Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 2004, 18: 1272-1282. 10.1101/gad.1199904.
Article
PubMed Central
CAS
PubMed
Google Scholar
Munoz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almodovar C, Palacios C, Lopez-Rivas A: Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J Biol Chem. 2003, 278: 12759-12768. 10.1074/jbc.M212392200.
Article
CAS
PubMed
Google Scholar
Acebo P, Giner D, Calvo P, Blanco-Rivero A, Ortega AD, Fernandez PL, Roncador G, Fernandez-Malave E, Chamorro M, Cuezva JM: Cancer abolishes the tissue type-specific differences in the phenotype of energetic metabolism. Transl Oncol. 2009, 2: 138-145.
Article
PubMed Central
PubMed
Google Scholar
Santamaria G, Martinez-Diez M, Fabregat I, Cuezva JM: Efficient execution of cell death in non-glycolytic cells requires the generation of ROS controlled by the activity of mitochondrial H+-ATP synthase. Carcinogenesis. 2006, 27: 925-935. 10.1093/carcin/bgi315.
Article
CAS
PubMed
Google Scholar
Rossignol R, Gilkerson R, Aggeler R, Yamagata K, Remington SJ, Capaldi RA: Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 2004, 64: 985-993. 10.1158/0008-5472.CAN-03-1101.
Article
CAS
PubMed
Google Scholar
Tomiyama A, Serizawa S, Tachibana K, Sakurada K, Samejima H, Kuchino Y, Kitanaka C: Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors Bax and Bak. J Natl Cancer Inst. 2006, 98: 1462-1473. 10.1093/jnci/djj395.
Article
CAS
PubMed
Google Scholar
Matsuyama S, Xu Q, Velours J, Reed JC: The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell. 1998, 1: 327-336. 10.1016/S1097-2765(00)80033-7.
Article
CAS
PubMed
Google Scholar
Fantin VR, St-Pierre J, Leder P: Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006, 9: 425-434. 10.1016/j.ccr.2006.04.023.
Article
CAS
PubMed
Google Scholar